InvestorsHub Logo

learningcurve2020

04/10/24 1:13 PM

#684391 RE: exwannabe #684377

And, all being run by an ex CIA Chief! Lol.

>>Secret approvals (Hiltonol) and secret BLAs. Right there with Merck having no need for facilities to design and manufacture vaccines.

dstock07734

04/10/24 2:13 PM

#684409 RE: exwannabe #684377

EX,

You made me laugh. Do you really believe your own nonsense?

The results on colorectal should be fabulous. IMO, the real combination should be DCVax-L + poly-iclc + keytruda since the trial was started after the poly-iclc trial stopped enrollment in January 2015 and poly-iclc was included in the UK compassionate use program starting in January 2016. You don't know that colorectal cancer has the TAM immuno-suppressive characteristic, do you? Now you should know what is the real motive behind the fact Merck fronted $4.5b to Daiichi.